Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.
Completion of Bioeconomy Fund 1
On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.
Investments
Timeline
Completion of Bioeconomy Fund 1
On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.
People
Rik Wehbring
Founder & managing director (San Francisco)
Rob Carlson
Founder & managing director (Seattle)
Tim Fell
Employee
Tim Gardner
Employee
Further reading
GBS 2018: Bioeconomy leaders foster shift to sustainable industry production
BIOCOM AG
News article
Xconomy: Seattle Area Had a Middling 2017 for Venture Investment, Fundraising
Benjamin Romano
News article
Documentaries, videos and podcasts
Companies
References
Bioeconomy Capital
San Francisco
Seattle
Automation
IndustrialCategories
Synthetic biologyInterdisciplinary branch of biology and engineering, applying multiple disciplines to build artificial biological systems for research, engineering, and medical applications.
CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
Related Topics
Cluster: Cell-based and plant-based meatA cluster of topics related to cultured meat, plant-based meat, and cellular agriculture.
BiotechnologyBiolotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
Contributors
- 1
Dawson Sewell
Seeking to explain science and technology through simple writing. - 2
Alex Dean
Masters in Biostatistics/Epidemiology @ UC Berkeley | BA in Biology @ Wesleyan University - 3
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Previously Co Founder of Heyzap. Investor in 100+ companies. Cantabrigian (Gonville and Caius). - 4
Carla Faraguna
Golden People and Operations.